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Under normal physiological conditions, mature human coronary artery smooth muscle cells (hCASMCs) exhibit a “contractile”
phenotype marked by low rates of proliferation and protein synthesis, but these cells possess the remarkable ability to
dediﬀerentiate into a “synthetic” phenotype when stimulated by conditions of pathologic stress. A variety of polyelectrolyte
multilayer (PEMU) ﬁlms are shown here to exhibit bioactive properties that induce distinct responses from cultured hCASMCs.
Surfaces terminated with Naﬁon or poly(styrenesulfonic acid) (PSS) induce changes in the expression and organization of
intracellular proteins, while a hydrophilic, zwitterionic copolymer of acrylic acid and 3-[2-(acrylamido)-ethyl dimethylammonio]
propanesulfonate(PAA-co-PAEDAPS)isresistanttocellattachmentandsuppressestheformationofkeycytoskeletalcomponents.
Diﬀerential expression of heat shock protein 90 and actin is observed, in terms of both their magnitude and cellular localization,
and distinct cytoplasmic patterns of vimentin are seen. The ionophoreA23187 induces contraction in conﬂuent hCASMCcultures
on Naﬁon-terminated surfaces. These results demonstrate that PEMU coatings exert direct eﬀects on the cytoskeletal organization
of attaching hCASMCs, impeding growth in some cases, inducing changes consistent with phenotypic modulation in others, and
suggesting potential utility for PEMU surfaces as a coating for coronary artery stents and other implantable medical devices.
1.Introduction
Vascular smooth muscle cells (VSMCs) are implicated as key
contributors to numerous vascular pathologies, including
atherosclerosis and the restenosis of angioplasty-treated
blood vessels in the presence or absence of coronary stents,
given their remarkable capacity for phenotypic modulation
in response to pathological stressors [1–7]. Rather than
achieving a state of terminal diﬀerentiation upon maturity,
VSMCs are capable of dediﬀerentiation through apparently
reversible pathways, as they transition between a “contrac-
tile” state marked by low rates of proliferation and protein
synthesis, and a “synthetic” state marked by an increase in
these parameters. An unknown number of transitional states
likely reside between these two extremes, and the possibility
that the transitory pathways between these two phenotypic
states may not be identical lends additional complexity to
this scenario [7]. There is also evidence that phenotypically
heterogeneous subpopulations of VSMCs may exist within
the arterial media itself [2, 6], but when placed into in
vitro culture systems, all SMCs tend to exhibit a synthetic
phenotype [6].
Phenotypic modulation of VSMCs has been reported in
vitro utilizing serum deprivation and readministration [8],
or growth surfaces coated with type IV collagen at speciﬁc
passages and time points of primary VSMC cultures [3].
For this study, the potential utility of thin polyelectrolyte
multilayer (PEMU) ﬁlms in the induction of phenotypic
modulation in such cells is explored. The PEMUs incor-
porated into this study were generated utilizing layer-by-
layer deposition [9, 10], in which a substrate is moved back
and forth between dilute baths of positively and negatively2 Biotechnology Research International
charged polyelectrolyte solutions, and multiple iterations of
thisprocessallowforthegradual,controlledbuildupofthese
coatings. The surfaces generated are uniform, durable, and
reproducible, and this process also allows for the coating of
substrates with complex geometries, such as the mesh-tube
geometry of implantable stenting devices.
PEMUs have been used to successfully control the
attachment of a variety of cell types including ﬁbroblasts
[11], primary hepatocytes [12], and neuron-like cells [13]
and have also been used to promote the colonization and
direct the diﬀerentiation of endothelial progenitor cells for
vascular grafts [14–18]. Previous studies utilizing a rat aortic
smooth muscle cell line (A7r5) cultured on diﬀerent PEMUs
have revealed changes suggestive of phenotypic modulation
[19–21], including variations in the mRNA expression of
smooth muscle α-actin, vimentin, and transgelin, an early
marker of SMC diﬀerentiation [21, 22].
The potential biological applications of cell culture
substrates are likely dependent on the ability of these
surfaces to mimic biological microenvironments [23]. The
aim of this study was to determine if SMCs derived from
the human coronary artery (hCASMCs) and cultured on
diﬀerent PEMU surfaces exhibited detectable variations
suggestive of phenotypic modulation, corresponding to
diﬀerent physiological microenvironments that can occur
in response to arterial injury, such as may occur during
stent implantation. Observable changes that were considered
included morphology, growth, contractility, and protein
expression in terms of both its magnitude and intracellular
localization.
2.MaterialsandMethods
2.1. Reagents. 1,3-Propane sulfone (PS), acrylic acid
(AA), poly(styrenesulfonic acid) (PSS; MW 7.3 × 104),
poly(diallyldimethylammonium chloride) (PDADMAC;
MW 3.7 × 105), poly(allylamine hydrochloride) (PAH;
MW ≈ 7 × 104), and poly(acrylic acid) (PAA; MW ≈
2.4 × 105) were used as received from Aldrich. 2-
(Acrylamido)-ethyl dimethylamine (AEDA) was obtained
from Monomer-Polymer & Dajac Inc. Poly(4-vinyl pyridine)
(P4VP; MW ≈ 5 × 104) was obtained from Polymer Source,
Inc. Naﬁon, a perﬂuorinated sulfonated polymer, was
purchased from Aldrich and used as a 0.3wt% solution in
ethanol:methanol 50:50 (vol/vol). All polymers (except
ﬂuorinated polymers), monomer, and buﬀer solutions were
prepared using 18MΩ water. Commercial antibodies were
obtained from Santa Cruz [HSP90 (H-114), isoforms of
actin (I-19)] and Sigma-Aldrich [α-smooth muscle actin
(1A4), vimentin (V9)]. Normal mouse IgG controls were
obtained from Biomeda, and normal rabbit IgG controls
were puriﬁed from rabbit serum by our laboratory. Alkaline
phosphatase- (AP-) conjugated secondary antibodies were
obtained from Sigma-Aldrich and ﬂuorophore-conjugated
secondary antibodies (Alexa Fluor 488 and 546) were
purchased from Molecular Probes (Invitrogen). Unless
noted otherwise, all components of routine buﬀering
systems were obtained from Sigma-Aldrich.
2.2. Polyelectrolyte Synthesis. The PAA-co-PAEDAPS copoly-
mer was prepared from 3-[2-(acrylamido)-ethyl dimethy-
lammonio] propane sulfonate (AEDAPS) [19] and AA via
free radical polymerization as described by McCormick
and Salazar [24], with a 90:10 AA:AEDAPS molar ratio.
The polymers were characterized using Fourier transform
infrared (FTIR) and attenuated total reﬂection FTIR, which
conﬁrmed the presence of carbonyl bond stretch C=O
(1725cm−1, AA; 1670cm−1, AEDAPS) and sulfonate bond
(νSO
−
3 )s t r e t c ha t∼1200cm−1. Poly(4-vinyl-trideca-ﬂuoro-
octylpyridiniumiodide)-co-poly(4-vinylpyridine)(PFPVP)
was synthesized to obtain a positively charged perﬂuorinated
polyelectrolyte for layering with the negatively charged
Naﬁon [25], and this polymer exhibited the distinctive C-F
bond stretch in the 1200-cm−1 region of the IR spectrum.
2.3. PEMU Coating on Glass Coverslips. Glass coverslips
(Corning no. 1.5, 22mm2) were ﬁrst cleaned in 70% H2SO4
(concentrated)/30% H2O2(aq) (“piranha”, a strong oxidizer
that should not be stored in a closed container). The cleaned
coverslips were rinsed in water and blown dry with a
stream of nitrogen. Polymer solution concentrations were
at 10mM (with respect to the monomer repeat unit) in
a 0.15M sodium chloride salt solution, with the exception
of Naﬁon, which was prepared as a 0.3wt% solution
in ethanol:methanol 50:50 vol/vol. Sequential adsorption
of polyelectrolytes onto the coverslips was performed by
automated deposition for 10min in each polymer solution
followed by three rinses with water for 1min each.
2.4. PEMU Nomenclature. For clarity, the following short-
hand is adopted for multilayers: (A/B)x where A is the
starting polyelectrolyte contacting the substrate (coverslip),
B is the terminating polyelectrolyte layer contacting the cells,
and x is the number of layer pairs.
2.5. Culture of hCASMCs. Human coronary artery smooth
muscle cells (hCASMCs) (BioWhittaker, Inc.) were rou-
tinely cultured in Smooth Muscle Basal Medium (SmBM,
Cambrex) in which 475mL of SmBM was supplemented
with 0.5mL human epidermal growth factor (hEGF), 0.5mL
insulin, 1.0mL human ﬁbroblast growth factor B (hFGF-
B) (all from Cambrex at 1μg/mL, SmGM-2 SingleQuots),
25mL (5%) fetal bovine serum (FBS) (Cambrex), and
0.5mL gentamicin/amphotericin-B (GA-1000) (Cambrex).
Cells were maintained at 37◦C in a humidiﬁed atmosphere
containing 5% CO2. All PEMU-coated coverslips were
equilibrated by contact with warm SmBM prior to cell
seeding.Allcell-basedassaysutilizedcellpassagesof6orless.
2.6. Growth Assays. Cell suspensions in SmBM were seeded
onto coated or uncoated glass coverslips (Corning no. 1.5)
at a uniform density of 10,000cells/cm2 a n dh o u s e di n6 -
well polystyrene tissue culture plates (Becton Dickinson)
for a period of ﬁve days with fresh media added on the
second and fourth days. Coverslips were gently dipped in
phosphate-buﬀeredsaline(PBS)priortotrypsinizationofall
attached cells, and the total number of cells recovered fromBiotechnology Research International 3
each coverslip was determined by hemocytometer. Assays
were repeated three times, and variations between the mean
values were analyzed using the least signiﬁcant diﬀerence
correction for one-way analysis of variance (ANOVA) for
multiple comparisons (Analyse-It for Microsoft Excel). Data
represent the mean ± S.E. from three separate experiments.
2.7. Two-Dimensional Gel Electrophoresis. Cultured
hCASMCs grown on coated or uncoated glass coverslips
as described were rinsed gently with PBS then lysed with
minimalbuﬀercontaining7Murea,2Mthiourea,2%3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS), 65mM dithiothreitol (DTT) and a broad-
spectrum protease inhibitor cocktail (Sigma, P2714). Cells
were removed with a cell scraper and transferred to a
siliconized tube for centrifugation at 17,000 ×gf o r2 0m i na t
4◦C. The supernatant was recovered and the precipitate was
discarded. The protein content of the collected fractions was
determined using the Coomassie Plus-Better Bradford Assay
Kit (Pierce), bovine serum albumin (BSA) standards, and
four replicates of each sample. Isoelectric focusing (IEF), the
ﬁrst dimension of separation, was accomplished utilizing
a Protean IEF Cell apparatus (Bio-Rad). Protein samples
were diluted into lysis buﬀer supplemented with ampholytes
(Bio-Rad) and fresh DTT prior to active rehydration at
50V for 12h at 20◦C using 11cm ReadyStrip Immobilized
pH Gradient (IPG) strips, pH 4 to 7 (Bio-Rad). Following
rehydration, the proteins were focused at 250V for 15min,
and then 8000V was maintained for a total of 60,000Vh/gel.
For the second dimension of separation, the IPG strips were
ﬁrstequilibratedfor10minin2.5mLofasolutionconsisting
of 375mM Tris-HCl (pH 8.8), 6M urea, 2% SDS, and 2%
DTT, followed by a second equilibration, for an additional
10min, in 2.5mL of a second equilibration buﬀer composed
of 375 mM Tris-HCl (pH 8.8), 6 M urea, 2% SDS, and 2.5%
iodoacetamide. The equilibrated IPG strips were washed
with cathode buﬀer (0.1M Tricine, 0.1M Tris-HCl (pH 8.2),
and 0.1% SDS) prior to separation on a 10% polyacrylamide
gel hand-casted using Criterion Cassettes (Bio-Rad). The
anode buﬀer was a 2M Tris-HCl (pH 8.9) solution. Gels
were electrophoresed at 50V for 30min, then at 100V
until the end of the separation. Gels were ﬁxed in 50%
methanol/7% acetic acid prior to staining with SYPRO Ruby
(Bio-Rad) and imaging with Typhoon Scanning Systems
(GE Healthcare). Gels were processed and compared using
ImageMaster 2D Platinum v6.0 (Amersham).
2.8. Matrix-Assisted Laser Desorption Ionization: Time of
Flight Mass Spectrometry (MALDI-TOF MS). Spots of inter-
est were excised for in-gel tryptic digestion. Excised frag-
ments were placed into a siliconized tube and exposed to
acetonitrile (ACN) for 15min. The shrunken fragments
were then allowed to air-dry prior to digestion with
activated trypsin (Pierce) at approximately 100 ng/sample
in a buﬀer containing 25mM ammonium bicarbonate.
Proteins contained within the gel fragments were digested at
30◦C overnight with agitation at 1500rpm. All tubes were
brieﬂy centrifuged the next morning, and the supernatant
was separated from the gel plug. All samples extracted
from the gel plugs were desalted with ZipTip C18 Tips
(Millipore) and eluted with a matrix solution comprised
of α-cyano-4-hydroxycinnamic acid (CHCA) (Sigma) at
4mg/mL dissolved in 50% ACN/0.1% triﬂouroacetic acid
(TFA) (Sigma). Eluted samples were applied directly to
a MALDI-TOF MS target plate and allowed to dry prior
to analysis utilizing an Axima CFR+ MALDI-TOF Mass
Spectrometer (Shimadzu Biotech). Spectra were calibrated
to known standards using the ProteoMass Peptide MALDI-
MS Calibration Kit (Sigma) incorporating ﬁve standard
peptides. All spectra were composed of 175 proﬁles for each
sample, and were processed using Kompact Software (Kratos
Analytical). Proteins were identiﬁed by their peptide mass
ﬁngerprint (PMF) utilizing MASCOT software against the
NCBI and Swiss-Prot databases, specifying monoisotopic
peaks of human taxonomy, 1 missed cleavage, and a peptide
tolerance of ±1Da. Fixed and variable chemical modiﬁca-
tions, including the carbamidomethylation of cysteine and
the oxidation of methionine, respectively, were taken into
consideration for these queries. Identities were accepted
or rejected based upon the extent of sequence coverage,
the magnitude of the MOlecular Weight SEarch (MOWSE)
probability score (>54), and the accuracy of both the pI and
molecular mass of the candidate protein.
2.9.WesternBlotting. Aliquotsofcelllysatesinthepreviously
described buﬀer containing equal volumes (5μg) of total
protein were combined with an SDS-containing buﬀer
(50mMTris,pH6.7,20mMethylenediaminetetraacetic acid
(EDTA), 5% Sucrose, 1.5% SDS, trace bromophenol blue,
and 1% fresh β-mercaptoethanol) prior to separation by
electrophoresis on 8% polyacrylamide gels. The proteins
contained in the gels were then transferred to a nitrocel-
lulose membrane utilizing 3-(cyclohexylamino)-1-propane
sulfonic acid (CAPS) buﬀer (100mM, pH 11) and a current
of 50volts for 90min at ambient temperature. Blots were
blocked overnight at 4◦C with gentle agitation in Tris-
buﬀered saline (TBS, pH 7.5) containing 4% BSA. Primary
antibodies and AP-conjugated secondary antibodies were
used at manufacturer-recommended dilutions, with incuba-
tion periods of two hours at ambient temperatures. Positive
bands were visualized following the addition of 5-bromo-
4-chloro-3-indoyl phosphate and nitro blue tetrazolium
(both from Fisher Scientiﬁc). Blotted membranes were
scanned and analyzed by integrated morphometry analysis
(Metamorph Systems) utilizing a uniform threshold for each
blotted membrane. Variations between the mean values were
analyzed using the least signiﬁcant diﬀerence correction for
one-way ANOVA for multiple comparisons. Data represent
the mean ± S.E. from three separate experiments.
2.10. Immunoﬂuorescence Confocal Microscopy. Cells grown
on each surface were washed twice with warm PBS (37◦C)
priortoﬁxationwithice-coldmethanol(−20◦C)forﬁvemin
(for actin and vimentin) or warm 3.7% paraformaldehyde in
50%PBSand50%SmBMfor15min(forHSP90).Following
another PBS wash, cells to be stained for HSP90 were4 Biotechnology Research International
permeabilized with 0.2% Triton X-100 in PBS for 15min.
All cells were washed three times with 0.05% Triton X-100
in PBS (PBST), and were treated identically from this point
forward. Samples were blocked with Image-iT FX Signal
Enhancer (Invitrogen) for 30min at room temperature in
a humid environment prior to incubation with primary
antibodies diluted in PBST for 60min, and puriﬁed preim-
mune IgGs from the same species were utilized as negative
controls. Following another washing phase, samples were
incubatedfor60mininadarkenvironmentwithAlexaFluor
488 or Alexa Fluor 546 (Invitrogen) secondary detection
conjugates diluted 1:250 in PBST. After a ﬁnal washing
phase, samples were dried and mounted using ProLong
Gold antifade reagent with 4
 ,6-diamidino-2-phenylindole
(DAPI) (Invitrogen), and were allowed to cure in a dark
environment for no less than 18 hours prior to visualization
of ﬂuorescent signals with a Zeiss LSM510 laser scanning
confocal microscope (Carl Zeiss, Germany) equipped with
a multiphoton laser. Wide-ﬁeld images of ﬂuorescent signals
were acquired using a Nikon Microphot FX equipped with a
100X objective and a Zeiss Axiocam.
2.11. Contraction Assays. Cells were cultured as previously
described. After ﬁve days growth, the calcium ionophore
A23187 (free acid, 98%, Fisher Scientiﬁc) was introduced
into wells at a ﬁnal concentration of 1μM. Stock concentra-
tions of 50mM were ﬁrst prepared in anhydrous dimethyl
sulfoxide (DMSO, Fisher Scientiﬁc), which was then diluted
into warm SmBM prior to addition. Equivalent volumes of
SmBM/DMSO alone were utilized for control experiments.
Contraction was monitored using a Zeiss Axiovert 35 micro-
scope in conjunction with a Hamamatsu Digital Camera
and Uniblitz Shutter Driver. Time-lapse image stacks were
processed using Metamorph Systems (Universal Imaging
Corp.).
3. Results
3.1. Cell Morphology and Growth on PEMU Surfaces. A
thickness of two-layer pairs is suﬃcient to coat the surface
of a glass substrate with few dispersed bumps [19, 26], and
given the thinness of these coatings the underlying glass
provided the dominant contribution to stiﬀness [27], which
allowed the eﬀects of chemical modiﬁcations at the cell-
substrate interface to be explored. Cells on uncoated glass
(Figure 1(a)) and (PFPVP/Naﬁon)2 (Figure 1(b)) displayed
a typical stellate morphology, and were indistinguishable
from one another during the early phases of a new culture.
Cells on (PDADMA/PSS)2 (Figure 1(c)) showed a marked
tendency towards aggregation, and with a higher percentage
of cells exhibiting membrane ruﬄing. Very few cells attached
to the (PAH/PAA-co-PAEDAPS)2 surface, and those that did
were almost exclusively rounded as opposed to ﬂat, with
numerous ﬁlopodia-like extensions of the cell membrane
extending in all directions (Figure 1(d)). The (PAH/PAA-
co-PAEDAPS)2 cultures never exhibited appreciable signs
of proliferation after this initial period of attachment
(Figure 1(h)), even when cultures were maintained for
Table 1: Cell growth after 5 days on PEMU surfaces.
Growth surface Cells/cm2 SE
%
Decrease
from glass
CI =
99%
Uncoated Glass 19782 ±1500 — ∗∗
(PFPVP/Naﬁon)2 9038 ±400 54.3% ∗
(PDADMA/PSS)2 8918 ±1300 54.9% ∗
(PAH/PAA-co-PAEDAPS)2 619 ±200 96.9% ∗∗
∗signiﬁcant variation from glass and (PAH/PAA-co-PAEDAPS)2 only;
∗∗signiﬁcant variation from all groups; data are reported as the mean ±
standard error (SE) of three separate experiments; CI: conﬁdence interval.
periods in excess of two weeks (data not shown). After
ﬁve days of growth, the number of cells obtained from
the (PFPVP/Naﬁon)2 and (PDADMA/PSS)2 surfaces were
statistically identical, and approximately half that obtained
from glass surfaces (Table 1). While the cells coated on
glass formed a uniform, conﬂuent layer, covering the entire
surface of the coverslips (Figure 1(e)), the cultures on the
(PFPVP/Naﬁon)2 surfaces exhibited a “hill and valley”
morphology [5, 28], in which dense clusters of cells were
interspersed with areas that were more sparsely populated
(Figure 1(f)). The cells on (PDADMA/PSS)2 exhibited a last-
ing tendency for aggregation, with an appearance most simi-
lartothatofthe(PFPVP/Naﬁon)2 cultures(Figure 1(g)).For
both the (PFPVP/Naﬁon)2 and (PDADMA/PSS)2 cultures,
the cells did not spread to the outer edges of the coverslip
(data not shown), which accounts for a signiﬁcant fraction
of their diminished numbers.
3.2. Diﬀerential Protein Expression on PEMU Surfaces. The
possibility of diﬀerential protein expression in these cul-
ture systems was investigated by two-dimensional gel elec-
trophoresis (2DE), although the cell-resistant (PAH/PAA-co-
PAEDAPS)2 surface did not yield enough cells for inclusion
into this phase of analysis. Six parallel cultures were pooled,
andsimilarpatternsofexpressionwererevealed(Figure 2).A
comparison between the glass and (PDADMA/PSS)2 sample
gels yielded a total of 390 protein spots on the “Master
gel” (a composite of both gel sets), where variations in the
“% volume” of the spots (normalizing the spot volumes of
the individual gels) in excess of 50% were observed in 117
spots. Using identical methods and criteria, a comparison
between the glass and (PFPVP/Naﬁon)2 gels also yielded 390
spots, with variations in 229 spots, while a direct comparison
between (PDADMA/PSS)2 and (PFPVP/Naﬁon)2 yielded
339 spots, with variations indicated in 147 spots. Of the
candidate proteins excised from these gels and identiﬁed
(Figure 3), diﬀerential expression was further supported
by Western blot analyses in two instances (Figure 4). The
highest levels of heat shock protein 90 (HSP90) expression
were consistently observed in hCASMCs collected from
(PDADMA/PSS)2 growth surfaces (Figure 4(a)), and its
expression was 8.4% higher than that seen on glass (CI =
95%), while the highest expression of actin was consistently
observed in hCASMCs collected from (PFPVP/Naﬁon)2
(Figure 4(b)), and was 38.6% higher than that seen onBiotechnology Research International 5
(a) Glass (b) Naﬁon
(c) PSS (d) PAA-co-PAEDAPS
(e) Glass (f) Naﬁon
(g) PSS (h) PAA-co-PAEDAPS
Figure 1: Morphology of hCASMC cultures on PEMU surfaces after 24 hours on (a) uncoated glass, (b) (PFPVP/Naﬁon)2,( c )
(PDADMA/PSS)2, and (d) (PAH/PAA-co-PAEDAPS)2. After 5 days, hCASMCs on (e) uncoated glass achieved a uniform, conﬂuent layer,
while cells on (f) (PFPVP/Naﬁon)2 exhibited a “hill and valley” morphology. Cells on (g) (PDADMA/PSS)2 exhibited continued aggregation
with a pattern similar to that seen on (PFPVP/Naﬁon)2, but with less alignment of the cells. Cultures on (h) (PAH/PAA-co-PAEDAPS)2 were
virtually unchanged after 5 days. All images are 100x. Scale bar = 20μm.6 Biotechnology Research International
90kDa
40kDa
Glass
(a)
PSS
(b)
Naﬁon
pH 4 pH 7
(c)
Figure 2: Two-dimensional separation of hCASMC lysates har-
vested from uncoated glass (top), (PDADMA/PSS)2 (bottom left),
and (PFPVP/Naﬁon)2 (bottom right). Representative gels show the
separation of 50μg of total protein separated from pH 4 to 7 on a
10%polyacrylamidegelstainedwithSYPRORubyandimagedwith
Typhoon Scanning Systems. White arrows correspond to excised
spots that were identiﬁed as HSP90 (top-left; MW: 85kDa, pI:
4.9, with α and β isoforms sharing these approximate values),
actin (bottom-right; MW 42kDa, pI: 5.2, with the β, γ,a n dα-SM
isoforms sharing these approximate values), and vimentin (center;
MW: 53kDa, pI: 5.1).
(PDADMA/PSS)2 (CI = 90%). Diﬀerences in the mean
abundance of vimentin were not signiﬁcant by Western
blotting (data not shown).
For HSP90, Mascot search algorithms returned a signiﬁ-
cant MOWSE (MOlecular Weight SEarch) probability score
for both the β (MOWSE: 123) and α (MOWSE: 71) isoforms
of this protein (Figure 3(a)), with sequence coverages of
40% and 34%, respectively. The two isoforms of human
HSP90, designated α and β, are more than 85% identical,
and there is only limited evidence in mammalian cells
for functional diﬀerences between the two [29]. Given the
relative similarities between the α and β isoforms of HSP90
in terms of their molecular mass (α: 85kDa, β: 83.5kDa)
and pI (α: 4.94, β: 4.97), with signiﬁcant MOWSE scores
obtained for either isoform, it was therefore considered
that the entirety of the excised spot was most likely some
combination of both isoforms. For actin, identical MOWSE
scores of 103 were returned for both the β and γ isoforms
(Figure 3(b)), with a similarly identical sequence coverage
for both forms, at 51%. Of the multiple isoforms of actin
that have been identiﬁed in mammalian smooth muscle, β
actin is the most widely expressed, while the α-SM actin
isoform is highly expressed in vascular smooth muscle, and
is specialized for contractile structures [3, 30]. The diﬀerent
isoforms of actin exhibit 95% homology in their amino acid
sequence [30], and as with the HSP family of proteins, given
the relative similarities between the actin isoforms in terms
of their molecular weight (α-SM: 42.3kDa, β: 42.1kDa, γ:
42.1kDa) and pI (α-SM: 5.23, β: 5.29, γ: 5.31), it is again
consideredthattheentiretyoftheexcisedspotwascomposed
of some combination of actin isoforms.
3.3. Intracellular Localization of HSP90. Given the relatively
small magnitude of variation in HSP90 expression, ﬂuores-
cent immunological cell staining was undertaken to study
the possible cellular context of this diﬀerence. HSP90 has
previously been found preferentially localized in the ruﬄing
membranes of adherent mouse lymphoma cells [31], and
hCASMCs cultured on (PDADMA/PSS)2 display a simi-
lar localization, designated by yellow arrows (Figure 5(c)),
that is absent on glass (Figure 5(a)), (PFPVP/Naﬁon)2
(Figure 5(b)), or (PAH/PAA-co-PAEDAPS)2 (Figure 5(d)).
3.4. Intracellular Localization of Actin Isoforms. Fluorescent
studies of actin also support a pattern of diﬀerential protein
expression on PEMU surfaces, particularly in terms of the
α-smooth muscle actin (α-SM actin) isoform (Figure 6).
Immunocytochemical double staining for multiple actin
isoforms (Figures 6(a), 6(c), 6(e),a n d6(g)), with α-SM actin
in green, the remaining isoforms in red, and blue nuclear
stainingwithDAPI,suggeststhatdiﬀerentialactinexpression
arises primarily from changes in the α-SM actin isoform.
On glass (Figure 6(a)), (PDADMA/PSS)2 (Figure 6(c)), and
(PFPVP/Naﬁon)2 (Figure 6(e)), expression of the non-α
isoforms (in red) appears fairly uniform, particularly when
compared to the expression of α-SM actin (in green) on the
(PFPVP/Naﬁon)2 surface, where intense staining of α-SM
actin ﬁlaments can be seen throughout the entirety of the
cell. Of particular note on the glass and (PDADMA/PSS)2
surfaces is the relative absence of actin ﬁlaments in the per-
inuclear regions, which may be associated with the increased
presence of organelles in these areas associated with protein
synthesis and a synthetic phenotype [3]. On the (PAH/PAA-
co-PAEDAPS)2 surface (Figure 6(g)), the isoforms of actin
are seen primarily at the cell perimeter, and even after ﬁve
days, multiple thin ﬁlopodia extend from the cell in every
direction seeking purchase on this in-hospitable surface.Biotechnology Research International 7
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Figure 3: MALDI-TOF MS peptide mass ﬁngerprints (PMFs) of (a) HSP-90, with inset showing probability-based MOWSE scores of 123
and 71 for the β and α isoforms, respectively, and (b) actin, with inset showing probability-based MOWSE scores of 103 for both the β and
γ isoforms. Proteins were identiﬁed by their PMF utilizing MASCOT software against the NCBI and Swiss-Prot databases.
When α-SM actin, this time stained red in the absence
of DAPI for enhanced visibility, is examined alone on these
surfaces (Figures 6(b), 6(d), 6(f),a n d6(h)) diminished
expression of α-SM actin ﬁlaments is again observed on
glass (Figure 6(b)) and (PDADMA/PSS)2 (Figure 6(d)), and
again, the ﬁlaments largely avoid the central regions of the
cell.Incontrast,theabundanceofα-SMactinﬁbersobserved
on(PFPVP/Naﬁon)2 (Figure 6(f))ﬁllthecytoplasm, extend-
ing from one end of the cell to the other, while staining of
the cells on (PAH/PAA-co-PAEDAPS)2 yield only a haze of
unpolymerized actin (Figure 6(h)), with any ﬁlaments that
might be present beyond the limits of detection.
3.5. Intracellular Localization of Vimentin. The cytoskeletal
protein vimentin was also identiﬁed from excised spots
(MOWSE: 156, sequence coverage: 56%), and while sub-
sequent blotting experiments failed to show diﬀerential
expression of this protein (data not shown), ﬂuorescent
immunostaining revealed striking diﬀerences in the cellular
localization of vimentin. On glass (Figure 7(a)), vimentin
expression is seen primarily in the cytoplasmic area sur-
rounding the nucleus, with only minimal expression in the
extended, stellate regions of the cell. The opposite trend is
observed on (PFPVP/Naﬁon)2 (Figure 7(b)), with staining
throughout the cytoplasm that extends to the outermost8 Biotechnology Research International
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Figure 4: Western blot analysis of (a) HSP90 and (b) α-SM actin. Blots represent 5 μgo ft o t a lp r o t e i nf r o mc e l ll y s a t e s ,w i t he a c hs e r i e s
of blots repeated three times. Histograms show the volume of bands expressed as a percentage of the maximum band in the presence of
a uniform threshold applied to each series of blots. (PDADMA/PSS)2 consistently generated the maximum threshold for HSP90 blots,
and (PFPVP/Naﬁon)2 consistently generated the maximum threshold when blots were probed speciﬁcally for α-SM actin (exclusive of
other isoforms). Signiﬁcant variation was seen in the expression of HSP90 when (PDADMA/PSS)2 was compared to uncoated glass, and
in the expression of α-SM actin when (PFPVP/Naﬁon)2 was compared to (PDADMA/PSS)2. Values are expressed as the mean ± S.E., with
variations in the means compared by 1-way ANOVA. ∗CI = 90%, ∗∗CI = 95%.
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Figure 5: Fluorescent staining for HSP90 on (a) uncoated glass, (b) (PFPVP/Naﬁon)2, (c) (PDADMA/PSS)2, and (d) (PAH/PAA-co-
PAEDAPS)2. Positive signals were detected with the Alexa Fluor 488 secondary antibody, conjugated to a green ﬂuorophore. Yellow arrows
(c) designate areas of concentrated HSP90 expression at the leading edge of cells on the (PDADMA/PSS)2 surface.Biotechnology Research International 9
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Figure 6: Fluorescent double staining for multiple actin isoforms (red) and α-SM actin (green) on (a) uncoated glass, (c) (PDADMA/PSS)2,
(e) (PFPVP/Naﬁon)2, and (g) (PAH/PAA-co-PAEDAPS)2. Positive signals were detected with Alexa Fluor 488 (green) and Alexa Fluor 546
(red) secondary antibodies. For double-stained images, nuclei are stained blue with DAPI. For enhanced clarity of the observed trends in
α-SM actin patterns of expression, ﬂuorescent staining exclusive for α-SM actin (red) in the absence of DAPI is shown on (b) uncoated glass,
(d) (PDADMA/PSS)2,( f)( P F P V P / N a ﬁ o n ) 2, and (h) (PAH/PAA-co-PAEDAPS)2, utilizing the Alexa Fluor 546 secondary antibody.10 Biotechnology Research International
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Figure 7: Fluorescent staining for vimentin on (a) uncoated glass, (b) (PFPVP/Naﬁon)2, (c, e) (PDADMA/PSS)2, and (d, f) (PAH/PAA-co-
PAEDAPS)2. The top four images (a)–(d) are confocal microscopy images in which positive signals are detected with the Alexa Fluor 546
secondaryantibodyconjugatedtoaredﬂuorophore,andcellnucleiarestainedbluewithDAPI.Thelowerimages(e,f)arewide-ﬁeldimages
at the same magniﬁcation for enhanced visualization of (e) the ﬁne mesh of intermediate ﬁlaments on the (PDADMA/PSS)2 surface and (f)
formation of the condensed “nuclear cap” on the (PAH/PAA-co-PAEDAPS)2 surface.
regions of the cell, and an alignment that might imply
association with a contractile microﬁlament network. The
(PDADMA/PSS)2 cultures oﬀer a third pattern of vimentin
expression (Figure 7(c)), revealed by wide-ﬁeld ﬂuorescence
(Figure 7(e)) as a ﬁne meshwork of the sort most commonly
ascribed to microtubule (MT) association. On (PAH/PAA-
co-PAEDAPS)2 surfaces, however, all evidence of vimentin
organization has vanished, with no indications of any
cytoskeletal structure whatsoever (Figure 7(d)). In many
cell types the absence of MT ﬁlaments is associated with
a localization of vimentin to a perinuclear “cap” [32].
The evidence for such an occurrence in the (PAH/PAA-
co-PAEDAPS)2 cultures is supported by wide-ﬁeld images
(Figure 7(f)) in which the signals for vimentin expression
at the “nuclear cap” are so strong and condensed that they
virtually overwhelm any other details in the image.
3.6. Cell Contraction on (PFPVP/Naﬁon)2. As described pre-
viously, conﬂuent hCASMC cultures on (PFPVP/Naﬁon)2
adopt a “hill and valley” morphology (Figure 8(a)), with
tightly packed areas of high cell density (the hills) being
separated by sparser areas populated with a lower densityBiotechnology Research International 11
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Figure 8: Contraction of hCASMC culture on a (PFPVP/Naﬁon)2 surface. Images are shown at (a) 0 minutes, (b) 2.5 minutes, (c) 3.5
minutes, and (d) 5 minutes after the initiation of contraction using the A23187 ionophore. A contractile “hill and valley” morphology (a) is
illustratedbythethickarrows(“hills”)andthethinarrows(“valleys”). Thisresponsewasnotobservedonglassor(PDADMA/PSS)2 cultures
exposed to the A23187 ionophore, nor was it seen in control (PFPVP/Naﬁon)2 cultures exposed to SmBM/DMSO alone, which served as the
vehicle for A23187 delivery (data not shown). (PAH/PAA-co-PAEDAPS)2 cultures were not tested by these methods. Representative image
stills are from an image stack of 100 images, all taken at 100x and processed using Metamorph Systems. Scale bar = 20μm.
of elongated cells (the valleys) [5, 28]. When cultures of
this type undergo contraction, induced here by the A23187
ionophore, the sparsely populated valleys are ravaged by the
lateral pulling forces from the hills that surround them on
either side. Over the course of approximately ﬁve minutes
(Figures 8(a)–8(d)), the cells in these less populous regions
are pulled taut by the neighboring cells in denser regions
before they ﬁnally give way, as the forcible detachment of
adhesion sites is common during contraction in culture
systems [30]. Once contraction has ceased, multiple holes
(Figure 8(d)) are found scattered throughout the valleys of
the culture, while the dense hills have become denser still.
Thisresponsewasnotobservedonglassor(PDADMA/PSS)2
cultures exposed to the A23187 ionophore, nor was it seen
in control (PFPVP/Naﬁon)2 cultures exposed to DMSO
alone, which served as the vehicle for A23187 delivery.
(PAH/PAA-co-PAEDAPS)2 cultures were not tested by these
methods.
4. Discussion
This study demonstrates that PEMU surfaces can be used to
alter many characteristics of hCASMCs in culture, and that
some of these alterations are consistent with changes linked
to phenotypic modulation. Previous investigations utilizing
a rat aortic smooth muscle cell line (A7r5) and a panel of
PEMU coatings revealed dramatic eﬀects on cell attachment
and cell spreading based upon the hydrophobicity and
surface charge of these growth surfaces, with hydrophobic
ﬁlms carrying a negative charge exhibiting the greatest
degree of cytophilicity, while a novel, hydrophilic zwitterion
displayed remarkable resistance to cell attachment [19, 20].
The three PEMU surfaces selected from these prior studies
for further analysis here are referred to now for simplicity
as “Naﬁon”, “PSS”, and “PAA-co-PAEDAPS”, in each instance
referencingtheoutermostlayercontactingtheventralsurface
of the attaching cells. Each PEMU surface was prepared
utilizing layer-by-layer deposition [9, 10] at a thickness of
two layer pairs to minimize swelling in buﬀer solution, as the
hydration and swelling of these ﬁlms can play a signiﬁcant
role in nonadhesion [11, 33, 34]. Each of the topmost layers
terminate with a sulfonate as their outermost functional
group, lending each of these surfaces a negative charge, or in
the case of the zwitterionic PAA-co-PAEDAPS, a net negative
charge. The Naﬁon, PSS, and PAA-co-PAEDAPS surfaces
vary in their hydrophobicity, with water contact angles of
100 (±5◦), 30 (±3◦), and 10 (±2◦), respectively [19]. As
each surface was coated onto glass, uncoated glass coverslips,
which naturally carry a negative charge, were utilized for
comparison.12 Biotechnology Research International
Naﬁon and PSS were selected in part for the demon-
strated biocompatibility. Naﬁon is resistant to damage by
blood [35] and has demonstrated utility as a component in
glucose biosensor systems for the management of diabetes
mellitus [36, 37]. PSS is similarly biocompatible and has
therapeutic utility as a potassium-binding resin for the
treatment of elevated potassium levels commonly known
as hyperkalemia [38]. PAA-co-PAEDAPS was designed to
mimic biological surfaces [19], as the majority of membrane
phospholipidheadgroupspossesazwitterioniccharacter,but
when included in a copolymer formulation at even a modest
concentration of 10%, PAA-co-PAEDAPS exhibits a near-
total resistance to cell attachment.
The growth of human cells on these selected PEMU
surfaces was diminished compared to glass in every instance,
most signiﬁcantly so in the case of PAA-co-PAEDAPS. While
cellular behaviors on PEMU ﬁlms are likely to be a function
of multiple factors as opposed to a single parameter [15],
reduced proliferation would be expected in the Naﬁon
cultures if indeed characteristics of the less proliferative
contractile phenotype were present. While there is no
evidenceforsimilarassumptionsinthePSScultures,itisalso
possiblethattheformationofcellaggregatesonPSSledtoan
early onset of normal contact inhibition [28].
Aside from the morphological ﬁndings, the presence of
diﬀerent phenotypes in these cultures is further suggested
by the observed ﬂuctuations in protein expression. While
variations in the expression of HSP90 and actin were not
profound in their magnitude, it is rather the intracellular
localization of these proteins that suggests alterations in
the cellular machinery that may be indicative of alternate
phenotypes. The highly localized areas of HSP90 found at
the leading edge of cell membrane ruﬄes in hCASMCs
cultured on PSS (Figure 5(c)) are intriguing given that the
HSP90α isoform is secreted extracellularly in an invasive
humanbreastcancercellline(MDA-MB-231),whereitlikely
contributes to the activation of matrix metalloproteinase-2
(gelatinase A, MMP-2), a potent proteolytic enzyme respon-
sible for the digestion of many extracellular matrix (ECM)
components by invasive cells [39]. Many of the paradigms
of tumor cell invasion, such as increased migration through
digested ECM, are similar to the processes at play during
the early stages of restenosis, as SMCs migrate from the
arterial media towards the lumen, and while increased MMP
expression is observed after coronary angioplasty in the
presence or absence of stent placement [40], the activation
of MMP-2 is even more pronounced in the wake of stent
implantation [41]. Thus, hCASMCs cultured on PSS imply
an invasive potential that is absent on the remainder of the
surfaces, suggesting that gelatinase activation might provide
one mechanism by which the HSPs contribute to hCASMC
invasion through the ECM that would otherwise conﬁne
them.
Invasion by hCASMCs is representative of the synthetic
phenotype, however, and the primary physiologic function
ofmature,contractilehCASMCsisthemaintenanceofblood
ﬂow and vascular tone [4]. The transition to a synthetic
phenotype is associated with a loss of contractility, and alter-
ations in both the expression and localization of cytoskeletal
and contractile proteins, such as actin, accompany this
modulation [3]; in rat aortic (A7r5) SMCs, exposure to
tumor-promoting phorbol esters has been shown to induce
ad e d i ﬀerentiated state [42] that is associated with a 70%
decrease in α-SM actin stress ﬁbers [43]. Of the surfaces
examined here, it is the well-developed network of α-
SM actin microﬁlaments on Naﬁon that appear the most
consistentwithandthemostpoisedforpotentialcontraction
events. Also of note is the curious amount of nuclear actin
staining observed on PSS, and while this is potentially an
artifact, it was not observed on the other surfaces that were
ﬁxed and stained using identical protocols. Actin is typically
consideredacytoplasmicprotein,butactintransportintothe
nucleus might nevertheless be mediated by binding partners
with nuclear location signals, such as coﬁlin, or simple
diﬀusionmightalsoaccomplishthistask,asnuclearporesare
suﬃciently wide to allow for the passage of actin monomers
[44].
Apart from actin, the expression of many cytoskeletal
proteins can serve as useful benchmarks in describing the
diﬀerentiated state of SMCs [1], as phenotypic modulation
is associated with numerous changes in the intracellular
localization of cytoskeletal proteins as contractile function
is gained or lost [3]. Another key cytoskeletal protein is
vimentin, a class III intermediate ﬁlament (IF) protein that
is primarily expressed in mesenchyme-derived cells, a group
that includes both endothelial and vascular SMCs [45].
Vimentin frequently coaligns with microtubule networks,
but has also been observed to form a meshwork that
ensheaths cellular stress ﬁbers [3], suggesting that vimentin
may also participate in the regulation of vascular tone [46],
or in the stabilization of microtubules, providing lateral
support and stability to microtubules that might otherwise
buckle during cell contraction [47]. There are reports that
the expression of vimentin varies in rabbit SMCs grown
on collagen IV to induce contractile phenotypes [3], and
conﬂicting reports that vimentin is amongst the cytoskeletal
proteins that remain constant in porcine SMCs induced into
phenotypic modulation by serum withdrawal [8]. The levels
of vimentin expression were found to remain constant under
the conditions of this study, but there was a striking variety
in intracellular localization that occurred independent of
any changes in magnitude. The ﬁlament-like ﬁbers seen on
Naﬁon that extend the length of the cell contrast starkly with
the ﬁne meshwork of strands observed on PSS (Figure 7).
This latter pattern of expression may be indicative of a
well-developed microtubule network and an increase in the
synthesis of proteins requiring vesicular transport, or there
may be a decrease in the amount of ﬁlamentous α-SM
actin available for vimentin association (Figures 6(c) and
6(d)), or perhaps a combination of both factors is at play,
as neither of these possibilities is at odds with the other.
The striking formation of the “nuclear cap” in the PAA-co-
PAEDAPS cells implies not only aberrant signaling processes
in these cells, as a lack of vimentin impairs the transduction
of chemical and mechanical stimuli from the vessel wall
[46], but also a disturbed spatial organization of focal
contact proteins and a disruption of actin microﬁlament
organization [48].Biotechnology Research International 13
To ascertain the presence of a functional contractile
apparatus in these cells, particularly in Naﬁon cultures that
exhibited a “hill and valley” morphology [5, 28]c o m -
bined with cytoskeletal features consistent with contraction,
the antibiotic A23187 (calcimycin, MW 523.6g/mol) was
utilized as an ionophore to facilitate the transmembrane
transport of calcium ions [49]. A23187 selectively binds
calcium ions with a 1:1 stoichiometry [50, 51], exchanging
two protons for a divalent metal ion to form a neutral species
that shields the charge of the ion during transport through
the hydrophobic interior of the lipid bilayer, increasing
intracellular stores of calcium and inducing contraction
[52]. When cultures grown to conﬂuence on Naﬁon surfaces
where exposed to this ionophore at a concentration of 1μM,
contraction was observed in these systems over the course of
several minutes.
In conclusion, evidence is presented here that layer-
by-layer assembled PEMU ﬁlms can indeed elicit a variety
of in vitro cellular responses from cultured hCASMCs
in terms of growth, morphology, protein expression, and
the organization, formation, or suppression of cytoskeletal
structures. Naﬁon-coated surfaces prompt the formation of
a well-developed network of α-SM actin microﬁlaments that
spans the cytoplasm and can be induced to contract. On PSS
surfaces, hCASMCs are most similar to those cultured on
uncoated glass, where perinuclear evacuation of α-SM actin
microﬁlaments implies an increased presence of synthetic
organelles, but a unique invasive potential is also suggested
by HSP90 localization to membrane ruﬄes at the leading
edge. On PAA-co-PAEDAPS, hCASMCs exhibit a total
absence of visible actin microﬁlaments and the formation
of a vimentin nuclear cap, implying the suppression of
key cytoskeletal components. These ﬁndings support an
emerging utility for PEMU surfaces, with the potential
to dictate cellular responses upon their introduction into
speciﬁc biological milieus, given that one of the primary
strengths of a multilayer coating strategy for implantable
devices would be their inﬂuence upon cells most proximal
to the device, exerting nonsystemic eﬀects in the most
localized fashion possible. Furthermore, control of the
PEMU deposition parameters aﬀords the opportunity to
ﬁne-tune these surfaces so as to direct or deter the growth
and attachment of selected cell types, or in the case of
hCASMCs, potentially inﬂuence the resultant phenotype of
attaching cells.
Acknowledgments
This work was supported in part by a Predoctoral Fel-
lowship (0415173B) from the American Heart Association
Florida/Puerto Rico Aﬃliate (to R. G. Newcomer), Grants
from the Florida State University (FSU) (to Q.-X. Sang
and J. B. Schlenoﬀ) and the National Institutes of Health
5R01EB006158 (to J. B. Schlenoﬀ a n dT .C .S .K e l l e r ) .T h e
authorsthankDr.D.TerryoftheFSUCollegeofMedicinefor
her expert assistance with 2DE and MALDI-TOF-MS, and
K.RiddleoftheFSUBiologicalScienceImagingResourcefor
her technical assistance with all aspects of microscopy.
References
[ 1 ]S .M .S c h w a r t z ,G .R .C a m p b e l l ,a n dJ .H .C a m p b e l l ,“ R e p l i -
cation of smooth muscle cells in vascular disease,” Circulation
Research, vol. 58, no. 4, pp. 427–444, 1986.
[2] M. G. Frid, E. P. Moiseeva, and K. R. Stenmark, “Multiple
phenotypically distinct smooth muscle cell populations exist
in the adult and developing bovine pulmonary arterial media
invivo,”CirculationResearch,vol.75,no.4,pp.669–681,1994.
[3] N.F .W orth,B.E.R olfe,J .Song,andG.R.Campbell,“V ascular
smooth muscle cell phenotypic modulation in culture is
associated with reorganisation of contractile and cytoskeletal
proteins,” Cell Motility and the Cytoskeleton,v o l .4 9 ,n o .3 ,p p .
130–145, 2001.
[4] M. Sata, A. Saiura, A. Kunisato et al., “Hematopoietic stem
cells diﬀerentiate into vascular cells that participate in the
pathogenesis of atherosclerosis,” Nature Medicine, vol. 8, no.
4, pp. 403–409, 2002.
[5] D. Simper, P. G. Stalboerger, C. J. Panetta, S. Wang, and N. M.
Caplice, “Smooth muscle progenitor cells in human blood,”
Circulation, vol. 106, no. 10, pp. 1199–1204, 2002.
[6] H. Hao, G. Gabbiani, and M.-L. Bochaton-Piallat, “Arterial
smooth muscle cell heterogeneity: implications for atheroscle-
rosis and restenosis development,” Arteriosclerosis, Thrombo-
sis, and Vascular Biology, vol. 23, no. 9, pp. 1510–1520, 2003.
[7] G. K. Owens, M. S. Kumar, and B. R. Wamhoﬀ, “Molecular
regulation of vascular smooth muscle cell diﬀerentiation in
development and disease,” Physiological Reviews, vol. 84, no.
3, pp. 767–801, 2004.
[8] C. Boccardi, A. Cecchettini, A. Caselli et al., “A proteomic
approach to the investigation of early events involved in
vascular smooth muscle cell activation,” Cell and Tissue
Research, vol. 328, no. 1, pp. 185–195, 2007.
[9] G. Decher, “Fuzzy nanoassemblies: toward layered polymeric
multicomposites,” Science, vol. 277, no. 5330, pp. 1232–1237,
1997.
[10] G. Decher and J. B. Schlenoﬀ,E d s . ,Multilayer Thin Films—
Sequential Assembly of Nanocomposite Materials, Wiley-VCH,
Weinheim, Germany, 2003.
[11] S. Y. Yang, J. D. Mendelsohn, and M. F. Rubner, “New class of
ultrathin, highly cell-adhesion-resistant polyelectrolyte multi-
layers with micropatterning capabilities,” Biomacromolecules,
vol. 4, no. 4, pp. 987–994, 2003.
[12] S. Kidambi, I. Lee, and C. Chan, “Controlling primary hepa-
tocyte adhesion and spreading on protein-free polyelectrolyte
multilayerﬁlms,”JournaloftheAmericanChemicalSociety,vol.
126, no. 50, pp. 16286–16287, 2004.
[13] S. P. Forry, D. R. Reyes, M. Gaitan, and L. E. Locascio,
“Facilitating the culture of mammalian nerve cells with
polyelectrolyte multilayers,” Langmuir, vol. 22, no. 13, pp.
5770–5775, 2006.
[14] C. Boura, P. Menu, E. Payan et al., “Endothelial cells grown
on thin polyelectrolyte mutlilayered ﬁlms: an evaluation of a
new versatile surface modiﬁcation,” Biomaterials, vol. 24, no.
20, pp. 3521–3530, 2003.
[15] C. Boura, S. Muller, D. Vautier et al., “Endothelial cell—
interactions with polyelectrolyte multilayer ﬁlms,” Biomateri-
als, vol. 26, no. 22, pp. 4568–4575, 2005.
[16] N. Berthelemy, H. Kerdjoudj, C. Gaucher et al., “Poly-
electrolyte ﬁlms boost progenitor cell diﬀerentiation into
endothelium-like monolayers,” Advanced Materials, vol. 20,
no. 14, pp. 2674–2678, 2008.14 Biotechnology Research International
[17] H. Kerdjoudj, N. Berthelemy, S. Rinckenbach et al., “Small
vessel replacement by human umbilical arteries with polyelec-
trolyte ﬁlm-treated arteries. In vivo behavior,” Journal of the
American College of Cardiology, vol. 52, no. 19, pp. 1589–1597,
2008.
[18] N.Berthelemy,H.Kerdjoudj,P.Schaafetal.,“O2levelcontrols
hematopoietic circulating progenitor cells diﬀerentiation into
endothelial or smooth muscle cells,” PloS one,v o l .4 ,n o .5 ,
article e5514, 2009.
[19] D. S. Salloum, S. G. Olenych, T. C. S. Keller, and J. B.
Schlenoﬀ, “Vascular smooth muscle cells on polyelectrolyte
multilayers: hydrophobicity-directed adhesion and growth,”
Biomacromolecules, vol. 6, no. 1, pp. 161–167, 2005.
[ 2 0 ]S .G .O l e n y c h ,M .D .M o u s s a l l e m ,D .S .S a l l o u m ,J .B .
Schlenoﬀ, and T. C. S. Keller, “Fibronectin and cell attach-
ment to cell and protein resistant polyelectrolyte surfaces,”
Biomacromolecules, vol. 6, no. 6, pp. 3252–3258, 2005.
[ 2 1 ]M .D .M o u s s a l l e m ,S .G .O l e n y c h ,S .L .S c o t t ,T .C .S .
Keller III, and J. B. Schlenoﬀ, “Smooth muscle cell phenotype
modulation and contraction on native and cross-linked
polyelectrolyte multilayers,” Biomacromolecules, vol. 10, no.
11, pp. 3062–3068, 2009.
[22] S.J.Assinder,J.-A.L.Stanton,andP.D.Prasad,“Transgelin:an
actin-binding protein and tumour suppressor,” International
JournalofBiochemistryandCellBiology,vol.41,no.3,pp.482–
486, 2009.
[23] A.J .Engle r ,C.C a ra g-K rieg e r ,C.P .J ohnso neta l.,“ Emb ry o nic
cardiomyocytesbeatbestonamatrixwithheart-likeelasticity:
scar-like rigidity inhibits beating,” Journal of Cell Science, vol.
121, no. 22, pp. 3794–3802, 2008.
[24] C. L. McCormick and L. C. Salazar, “Water soluble copoly-
mers: 46. Hydrophilic sulphobetaine copolymers of acry-
lamide and 3-(2-acrylamido-2-methylpropanedimethylam-
monio)-1-propanesulphonate,” Polymer, vol. 33, no. 21, pp.
4617–4624, 1992.
[25] R. M. Ji Sr., H. H. Rmaile, and J. B. Schlenoﬀ, “Hydrophobic
and ultrahydrophobic multilayer thin ﬁlms from perﬂuo-
rinated polyelectrolytes,” Angewandte Chemie—International
Edition, vol. 44, no. 5, pp. 782–785, 2005.
[26] S. Diziain, J. Dejeu, L. Buisson, D. Charraut, F. Membrey,
and A. Foissy, “Investigations in the initial build-up stages of
polyelectrolyte multilayers by laser reﬂectometry and atomic
force microscopy,” Thin Solid Films, vol. 516, no. 1, pp. 1–7,
2007.
[ 2 7 ]S .M e h r o t r a ,S .C .H u n l e y ,K .M .P a w e l e ce ta l . ,“ C e l la d h e s i v e
behavior on thin polyelectrolyte multilayers: cells attempt to
achievehomeostasisofitsadhesionenergy,”Langmuir,vol.26,
no. 15, pp. 12794–12802, 2010.
[28] P. L. Faries, D. I. Rohan, H. Takahara et al., “Human vascular
smooth muscle cells of diabetic origin exhibit increased
proliferation, adhesion, and migration,” Journal of Vascular
Surgery, vol. 33, no. 3, pp. 601–607, 2001.
[29] D. Picard, “Hsp90 invades the outside,” Nature Cell Biology,
vol. 6, no. 6, pp. 479–480, 2004.
[30] M. E. Fultz, C. Li, W. Geng, and G. L. Wright, “Remodeling of
the actin cytoskeleton in the contracting A7r5 smooth muscle
cell,” Journal of Muscle Research and Cell Motility, vol. 21, no.
8, pp. 775–787, 2000.
[31] S. Koyasu, E. Nishida, T. Kadowaki et al., “Two mammalian
heat shock proteins, HSP90 and HSP100, are actin-binding
proteins,”ProceedingsoftheNationalAcademyofSciencesofthe
United States of America, vol. 83, no. 21, pp. 8054–8058, 1986.
[32] F. K. Gyoeva and V. I. Gelfand, “Coalignment of vimentin
intermediate ﬁlaments with microtubules depends on
kinesin,” Nature, vol. 353, no. 6343, pp. 445–448, 1991.
[33] C. Picart, J. Mutterer, L. Richert et al., “Molecular basis for
the explanation of the exponential growth of polyelectrolyte
multilayers,” Proceedings of the National Academy of Sciences of
the United States of America, vol. 99, no. 20, pp. 12531–12535,
2002.
[34] L. Richert, P. Lavalle, E. Payan et al., “Layer by layer buildup of
polysaccharide ﬁlms: physical chemistry and cellular adhesion
aspects,” Langmuir, vol. 20, no. 2, pp. 448–458, 2004.
[35] C. Heitner-Wirguin, “Recent advances in perﬂuorinated
ionomer membranes: structure, properties and applications,”
Journal of Membrane Science, vol. 120, no. 1, pp. 1–33, 1996.
[ 3 6 ]W .K .W a r d ,L .B .J a n s e n ,E .A n d e r s o n ,G .R e a c h ,J . - C .K l e i n ,
and G. S. Wilson, “A new amperometric glucose microsensor:
in vitro and short-term in vivo evaluation,” Biosensors and
Bioelectronics, vol. 17, no. 3, pp. 181–189, 2002.
[ 3 7 ]X .K a n g ,Z .M a i ,X .Z o u ,P .C a i ,a n dJ .M o ,“ As e n s i t i v e
nonenzymatic glucose sensor in alkaline media with a cop-
per nanocluster/multiwall carbon nanotube-modiﬁed glassy
carbon electrode,” Analytical Biochemistry, vol. 363, no. 1, pp.
143–150, 2007.
[38] S. Inaba, K. Nibu, H. Takano et al., “Potassium-adsorption ﬁl-
ter for RBC transfusion: a phase III clinical trial,” Transfusion,
vol. 40, no. 12, pp. 1469–1474, 2000.
[39] B. K. Eustace, T. Sakurai, J. K. Stewart et al., “Functional
proteomic screens reveal an essential extracellular role for
hsp90α in cancer cell invasiveness,” Nature Cell Biology, vol.
6, no. 6, pp. 507–514, 2004.
[40] M. J. Sierevogel, G. Pasterkamp, D. P. V. de Kleijn, and B.
H. Strauss, “Matrix metalloproteinases: a therapeutic target in
cardiovascular disease,” Current Pharmaceutical Design, vol. 9,
no. 13, pp. 1033–1040, 2003.
[41] L. J. Feldman, M. Mazighi, A. Scheuble et al., “Diﬀerential
expression of matrix metalloproteinases after stent implan-
tation and balloon angioplasty in the hypercholesterolemic
rabbit,” Circulation, vol. 103, no. 25, pp. 3117–3122, 2001.
[42] G. Burgstaller and M. Gimona, “Podosome-mediated matrix
resorption and cell motility in vascular smooth muscle
cells,” American Journal of Physiology—Heart and Circulatory
Physiology, vol. 288, no. 6, pp. H3001–H3005, 2005.
[43] D. Brown, A. Dykes, J. Black, S. Thatcher, M. E. Fultz, and
G. L. Wright, “Diﬀerential actin isoform reorganization in
the contracting A7r5 cell,” Canadian Journal of Physiology and
Pharmacology, vol. 84, no. 8-9, pp. 867–875, 2006.
[44] B. M. Jockusch, C.-A. Schoenenberger, J. Stetefeld, and U.
Aebi, “Tracking down the diﬀerent forms of nuclear actin,”
Trends in Cell Biology, vol. 16, no. 8, pp. 391–396, 2006.
[45] E. Fuchs and K. Weber, “Intermediate ﬁlaments: structure,
dynamics, function, and disease,” Annual Review of Biochem-
istry, vol. 63, pp. 345–382, 1994.
[46] F. Terzi, D. Henrion, E. Colucci-Guyon et al., “Reduction
of renal mass is lethal in mice lacking vimentin: role of
endothelin-nitric oxide imbalance,” Journal of Clinical Inves-
tigation, vol. 100, no. 6, pp. 1520–1528, 1997.
[47] N. Wang and D. Stamenovic, “Mechanics of vimentin
intermediate ﬁlaments,” Journal of Muscle Research and Cell
Motility, vol. 23, no. 5-6, pp. 535–540, 2002.
[48] B. Eckes, D. Dogic, E. Colucci-Guyon et al., “Impaired
mechanical stability, migration and contractile capacity in
vimentindeﬁcientﬁbroblasts,”J o urnalo fC ellScience,vol.111,
no. 13, pp. 1897–1907, 1998.Biotechnology Research International 15
[ 4 9 ] J .J .M u r r a y ,P .W .R e e d ,a n dF .S .F a y ,“ C o n t r a c t i o no fi s o l a t e d
smooth muscle cells by ionophore A23187,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 72, no. 11, pp. 4459–4463, 1975.
[50] M. A. Kolber and D. H. Haynes, “Fluorescence study of the
divalent cation-transport mechanism of ionophore A23187 in
phospholipid membranes,” Biophysical Journal,v o l .3 6 ,n o .2 ,
pp. 369–391, 1981.
[51] C. J. Chapman, A. K. Puri, R. W. Taylor, and D. R.
Pfeiﬀer, “General features in the stoichiometry and stability
of ionophore A23187-cation complexes in homogeneous
solution,” Archives of Biochemistry and Biophysics, vol. 281, no.
1, pp. 44–57, 1990.
[52] C. M. Deber and D. R. Pfeiﬀer, “Ionophore A23187. Solution
conformations of the calcium complex and free acid deduced
from proton and carbon-13 nuclear magnetic resonance
studies,” Biochemistry, vol. 15, no. 1, pp. 132–141, 1976.